LOOK AT THIS IF YOU'RE INTERESTED IN:
Examining the economic costs of treating rotavirus illness.
HOW YOU CAN USE THIS MATERIAL:
Stakeholders from Ministries of Health, Ministries of Finance, National Immunisation Technical Advisory Groups (NITAGs), and other groups can utilize the data contained in this report to advocate for the affordability of the rotavirus vaccine and the value of these vaccines.
This brief, developed by the Rotavirus Organization of Technical Allies (ROTA), examines the cost of rotavirus to governments, health systems, and families, the affordability of the rotavirus vaccine, and the value of these vaccines. The brief also features a global analysis which found that improving the timeliness and coverage of rotavirus vaccination can substantially increase its impact and cost-effectiveness.